tetano
Editor, Senior Moderator
Adv Exp Med Biol. 2018 Sep 11. doi: 10.1007/5584_2018_230. [Epub ahead of print]
[h=1]Detection of Influenza in the Epidemic Season 2016/2017 Based on I-MOVE+ Project.[/h] Hallmann-Szelińska E[SUP]1[/SUP], Cieślak K[SUP]2[/SUP], Szymański K[SUP]2[/SUP], Kowalczyk D[SUP]2[/SUP], Korczyńska MR[SUP]3[/SUP], Paradowska-Stankiewicz I[SUP]3[/SUP], Brydak LB[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] In the influenza season 2016/2017 in Europe, the predominant virus was A/H3N2/. In Poland, the percentage of people vaccinated against influenza was 3.33%. European I-MOVE+ project shows how important it is to monitor the effectiveness of influenza vaccine. The project demonstrates that a match between the circulating vaccine strains and those included in the vaccine for the Northern Hemisphere was low-to-moderate. In the present study, there were 379 patients and 296 control subjects examined in hospitals in Poland as part of I-MOVE+ project. The real-time reverse transcription polymerase chain reaction (qRT-PCR) method was used to detect the influenza virus in all subjects. We detected the influenza subtype A/H3N2/ in 59.1% and type B virus in 2.1%. There was one co-infection of subtype A/H3N2/ with subtype A/H1N1/ and eight co-infections of type B with subtype A/H3N2/. No influenza viruses were detected in the control group. Only 19 patients and 22 control subjects were vaccinated during the epidemic season in question. A proportion of people vaccinated against influenza in Poland remains dismally low compared to other European countries.
[h=4]KEYWORDS:[/h] Epidemic season; Influenza; Laboratory testing; Subtype; Vaccine
PMID: 30203342 DOI: 10.1007/5584_2018_230
[h=1]Detection of Influenza in the Epidemic Season 2016/2017 Based on I-MOVE+ Project.[/h] Hallmann-Szelińska E[SUP]1[/SUP], Cieślak K[SUP]2[/SUP], Szymański K[SUP]2[/SUP], Kowalczyk D[SUP]2[/SUP], Korczyńska MR[SUP]3[/SUP], Paradowska-Stankiewicz I[SUP]3[/SUP], Brydak LB[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] In the influenza season 2016/2017 in Europe, the predominant virus was A/H3N2/. In Poland, the percentage of people vaccinated against influenza was 3.33%. European I-MOVE+ project shows how important it is to monitor the effectiveness of influenza vaccine. The project demonstrates that a match between the circulating vaccine strains and those included in the vaccine for the Northern Hemisphere was low-to-moderate. In the present study, there were 379 patients and 296 control subjects examined in hospitals in Poland as part of I-MOVE+ project. The real-time reverse transcription polymerase chain reaction (qRT-PCR) method was used to detect the influenza virus in all subjects. We detected the influenza subtype A/H3N2/ in 59.1% and type B virus in 2.1%. There was one co-infection of subtype A/H3N2/ with subtype A/H1N1/ and eight co-infections of type B with subtype A/H3N2/. No influenza viruses were detected in the control group. Only 19 patients and 22 control subjects were vaccinated during the epidemic season in question. A proportion of people vaccinated against influenza in Poland remains dismally low compared to other European countries.
[h=4]KEYWORDS:[/h] Epidemic season; Influenza; Laboratory testing; Subtype; Vaccine
PMID: 30203342 DOI: 10.1007/5584_2018_230